From March 29th to 31st, the annual scientific congress for the American College of Cardiology (ACC) will be held at Washington, DC. Thought leaders congregate to discuss prevention, diagnosis and treatment of cardiovascular disease. This year, George Clinical will be represented by Professor Bruce Neal and Professor Henry Krum. See you there!
Read More
FoodSwitch, a leading health app, has just been awarded “Most Valuable HCP or Health Care Initiative Award” at the eyeforpharma conference in Barcelona
Read More
Packaged foods can often be high in salt, fat and sugar where excessive consumption can lead to development of chronic diseases. Foodswitch is an app created by The George Institute to see what’s in the food you’re eating and make better food choices when grocery shopping. With the Foodswitch app, users scan a product to […]
Read More
Recently, the FDA said it will review possible heart risks associated with saxagliptin, a widely used diabetes drug.
Read More
George Clinical in China would like to wish all of our clients, sponsors and investigators the best wishes for Lunar New Year.
Read More
A diabetes epidemic is upon us, despite improved knowledge and therapy on this disease. The recently published 6th edition of the International Diabetes Federation Atlas provides some alarming figures.
Read More
It is an exciting time as risk-based monitoring (RBM) application grows throughout industry.
Read More
Most of us at industry would be more familiar with traditional contract research organizations (CROs) than academically led research organizations (AROs). The broad range of organizations that carry the term AROs does lead to confusion, and its not until fairly recently that the definition of an ARO within a clinical trial setting was well defined. […]
Read More
The George Clinical Data Management group offers end to end Data Management services for phase I – IV and post-marketing clinical trials, as well as tailored services for academic research trials. Our goal is to provide flexible solutions for our customers and we offer a range of database options to suit study requirements. Fully validated […]
Read More
Cinacalcet is a drug that lowers levels of parathyroid hormone, a factor that is increased in almost all people with kidney failure and has been linked to an increased risk of fracture, cardiovascular events and death. It has been hoped that by reducing parathyroid hormone with cinacalcet, the risk of these clinical events will also […]
Read More
